US8663671B2 - Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity - Google Patents
Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity Download PDFInfo
- Publication number
- US8663671B2 US8663671B2 US12/612,881 US61288109A US8663671B2 US 8663671 B2 US8663671 B2 US 8663671B2 US 61288109 A US61288109 A US 61288109A US 8663671 B2 US8663671 B2 US 8663671B2
- Authority
- US
- United States
- Prior art keywords
- hydrogel
- capsules
- eud
- tobacco
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 266
- 239000002775 capsule Substances 0.000 title claims abstract description 243
- 239000000203 mixture Substances 0.000 title abstract description 22
- 238000000034 method Methods 0.000 title abstract description 14
- 230000035699 permeability Effects 0.000 title abstract description 8
- 229920000615 alginic acid Polymers 0.000 claims abstract description 82
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 81
- 229940072056 alginate Drugs 0.000 claims abstract description 75
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 74
- 206010016807 Fluid retention Diseases 0.000 claims abstract description 38
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 65
- 241000208125 Nicotiana Species 0.000 claims description 59
- 239000011159 matrix material Substances 0.000 claims description 54
- 238000000576 coating method Methods 0.000 claims description 45
- 239000011248 coating agent Substances 0.000 claims description 40
- 239000000796 flavoring agent Substances 0.000 claims description 31
- 235000019634 flavors Nutrition 0.000 claims description 31
- 235000019505 tobacco product Nutrition 0.000 claims description 16
- 239000012188 paraffin wax Substances 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- 239000004816 latex Substances 0.000 claims description 6
- 229920000126 latex Polymers 0.000 claims description 6
- 230000000391 smoking effect Effects 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 4
- 235000019504 cigarettes Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 230000009477 glass transition Effects 0.000 claims description 3
- 239000002417 nutraceutical Substances 0.000 claims description 3
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 2
- 239000003905 agrochemical Substances 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 125000005395 methacrylic acid group Chemical group 0.000 claims description 2
- 239000006143 cell culture medium Substances 0.000 claims 1
- 239000011247 coating layer Substances 0.000 abstract description 92
- 239000008199 coating composition Substances 0.000 abstract description 18
- 239000011324 bead Substances 0.000 abstract description 13
- 229920003134 Eudragit® polymer Polymers 0.000 description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 48
- 239000000463 material Substances 0.000 description 26
- 239000001993 wax Substances 0.000 description 22
- -1 acrylamidomethyl Chemical group 0.000 description 18
- 229920000642 polymer Polymers 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 229920003138 Eudragit® L 30 D-55 Polymers 0.000 description 14
- 239000000306 component Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 230000014759 maintenance of location Effects 0.000 description 12
- 239000000284 extract Substances 0.000 description 11
- 230000002209 hydrophobic effect Effects 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 9
- 235000010418 carrageenan Nutrition 0.000 description 9
- 239000000679 carrageenan Substances 0.000 description 9
- 229920001525 carrageenan Polymers 0.000 description 9
- 229940113118 carrageenan Drugs 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 9
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 244000061176 Nicotiana tabacum Species 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 235000010987 pectin Nutrition 0.000 description 8
- 239000001814 pectin Substances 0.000 description 8
- 229920001277 pectin Polymers 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 238000000113 differential scanning calorimetry Methods 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003906 humectant Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000003352 sequestering agent Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000004203 carnauba wax Substances 0.000 description 5
- 229940082483 carnauba wax Drugs 0.000 description 5
- 235000013869 carnauba wax Nutrition 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000000945 filler Substances 0.000 description 5
- 238000010348 incorporation Methods 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 235000019809 paraffin wax Nutrition 0.000 description 5
- 235000019271 petrolatum Nutrition 0.000 description 5
- 230000002035 prolonged effect Effects 0.000 description 5
- 230000009919 sequestration Effects 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000008358 core component Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000014749 Mentha crispa Nutrition 0.000 description 3
- 244000078639 Mentha spicata Species 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000007373 indentation Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N Benzylformate Chemical compound O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 235000019501 Lemon oil Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 241000208126 Nicotiana acuminata Species 0.000 description 2
- 241001144493 Nicotiana obtusifolia Species 0.000 description 2
- 241001144488 Nicotiana occidentalis Species 0.000 description 2
- 241000493375 Nicotiana quadrivalvis Species 0.000 description 2
- 241001144498 Nicotiana rosulata subsp. ingulba Species 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000008122 artificial sweetener Substances 0.000 description 2
- 235000021311 artificial sweeteners Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000019506 cigar Nutrition 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 150000002433 hydrophilic molecules Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- RGFNRWTWDWVHDD-UHFFFAOYSA-N isobutyl butyrate Chemical compound CCCC(=O)OCC(C)C RGFNRWTWDWVHDD-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000010501 lemon oil Substances 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N pentanal Chemical compound CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011253 protective coating Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 229940098795 (3z)- 3-hexenyl acetate Drugs 0.000 description 1
- 239000001730 (5R)-5-butyloxolan-2-one Substances 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229910002710 Au-Pd Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- ICMAFTSLXCXHRK-UHFFFAOYSA-N Ethyl pentanoate Chemical compound CCCCC(=O)OCC ICMAFTSLXCXHRK-UHFFFAOYSA-N 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004348 Glyceryl diacetate Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- YKVWPZJHENXDAJ-VOTSOKGWSA-N Megastigmatrienone Chemical compound CC1=CC(=O)CC(C)(C)C1\C=C\C=C YKVWPZJHENXDAJ-VOTSOKGWSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 241000250374 Nicotiana acaulis Species 0.000 description 1
- 241001144497 Nicotiana africana Species 0.000 description 1
- 244000061322 Nicotiana alata Species 0.000 description 1
- 241000250377 Nicotiana amplexicaulis Species 0.000 description 1
- 241001144490 Nicotiana arentsii Species 0.000 description 1
- 241000228653 Nicotiana attenuata Species 0.000 description 1
- 241000250375 Nicotiana benavidesii Species 0.000 description 1
- 241000207746 Nicotiana benthamiana Species 0.000 description 1
- 241000250376 Nicotiana bonariensis Species 0.000 description 1
- 241000250373 Nicotiana cavicola Species 0.000 description 1
- 241001609967 Nicotiana clevelandii Species 0.000 description 1
- 241001244271 Nicotiana cordifolia Species 0.000 description 1
- 241001144496 Nicotiana corymbosa Species 0.000 description 1
- 241000208113 Nicotiana debneyi Species 0.000 description 1
- 241000862464 Nicotiana excelsior Species 0.000 description 1
- 244000006449 Nicotiana forgetiana Species 0.000 description 1
- 241000208128 Nicotiana glauca Species 0.000 description 1
- 241001495644 Nicotiana glutinosa Species 0.000 description 1
- 241001144503 Nicotiana goodspeedii Species 0.000 description 1
- 241000250366 Nicotiana gossei Species 0.000 description 1
- 241000579278 Nicotiana kawakamii Species 0.000 description 1
- 241000250368 Nicotiana knightiana Species 0.000 description 1
- 241000250019 Nicotiana langsdorffii Species 0.000 description 1
- 241000250027 Nicotiana linearis Species 0.000 description 1
- 241000250024 Nicotiana longiflora Species 0.000 description 1
- 241001144499 Nicotiana maritima Species 0.000 description 1
- 241000250031 Nicotiana megalosiphon Species 0.000 description 1
- 241000250030 Nicotiana miersii Species 0.000 description 1
- 241000250041 Nicotiana noctiflora Species 0.000 description 1
- 241000228665 Nicotiana nudicaulis Species 0.000 description 1
- 241001144504 Nicotiana occidentalis subsp. hesperis Species 0.000 description 1
- 241000208132 Nicotiana otophora Species 0.000 description 1
- 241000876839 Nicotiana paniculata Species 0.000 description 1
- 241001144492 Nicotiana pauciflora Species 0.000 description 1
- 241000250042 Nicotiana petunioides Species 0.000 description 1
- 241000208133 Nicotiana plumbaginifolia Species 0.000 description 1
- 241001144487 Nicotiana raimondii Species 0.000 description 1
- 241001290303 Nicotiana repanda Species 0.000 description 1
- 241001144500 Nicotiana rosulata Species 0.000 description 1
- 241001144486 Nicotiana rotundifolia Species 0.000 description 1
- 241000208134 Nicotiana rustica Species 0.000 description 1
- 241001144491 Nicotiana setchellii Species 0.000 description 1
- 241000250044 Nicotiana simulans Species 0.000 description 1
- 241000249970 Nicotiana solanifolia Species 0.000 description 1
- 241001144495 Nicotiana spegazzinii Species 0.000 description 1
- 241000249966 Nicotiana stocktonii Species 0.000 description 1
- 241001144480 Nicotiana suaveolens Species 0.000 description 1
- 241000208136 Nicotiana sylvestris Species 0.000 description 1
- 241001144489 Nicotiana thyrsiflora Species 0.000 description 1
- 241000579280 Nicotiana tomentosa Species 0.000 description 1
- 241000208138 Nicotiana tomentosiformis Species 0.000 description 1
- 241000249968 Nicotiana umbratica Species 0.000 description 1
- 241000228669 Nicotiana velutina Species 0.000 description 1
- 241001144494 Nicotiana wigandioides Species 0.000 description 1
- 240000002061 Nothoscordum fragrans Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- AZFUASHXSOTBNU-UHFFFAOYSA-N Propyl 2-methylpropanoate Chemical compound CCCOC(=O)C(C)C AZFUASHXSOTBNU-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 239000008376 breath freshener Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000007444 cell Immobilization Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- NPFVOOAXDOBMCE-PLNGDYQASA-N cis-3-Hexenyl acetate Natural products CC\C=C/CCOC(C)=O NPFVOOAXDOBMCE-PLNGDYQASA-N 0.000 description 1
- RRGOKSYVAZDNKR-ARJAWSKDSA-M cis-3-hexenylacetate Chemical compound CC\C=C/CCCC([O-])=O RRGOKSYVAZDNKR-ARJAWSKDSA-M 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- WTOYNNBCKUYIKC-UHFFFAOYSA-N dl-nootkatone Natural products C1CC(C(C)=C)CC2(C)C(C)CC(=O)C=C21 WTOYNNBCKUYIKC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000000724 energy-dispersive X-ray spectrum Methods 0.000 description 1
- 238000002389 environmental scanning electron microscopy Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- IPBFYZQJXZJBFQ-UHFFFAOYSA-N gamma-octalactone Chemical compound CCCCC1CCC(=O)O1 IPBFYZQJXZJBFQ-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 235000019443 glyceryl diacetate Nutrition 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- JSLCOZYBKYHZNL-UHFFFAOYSA-N isobutyric acid butyl ester Natural products CCCCOC(=O)C(C)C JSLCOZYBKYHZNL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000010935 mono and diglycerides of fatty acids Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 150000004005 nitrosamines Chemical class 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- JXAZAUKOWVKTLO-UHFFFAOYSA-L sodium pyrosulfate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)OS([O-])(=O)=O JXAZAUKOWVKTLO-UHFFFAOYSA-L 0.000 description 1
- PQDRXUSSKFWCFA-CFNZNRNTSA-N solanone Chemical compound CC(=O)CC[C@@H](C(C)C)\C=C\C(C)=C PQDRXUSSKFWCFA-CFNZNRNTSA-N 0.000 description 1
- PQDRXUSSKFWCFA-UHFFFAOYSA-N solanone Natural products CC(=O)CCC(C(C)C)C=CC(C)=C PQDRXUSSKFWCFA-UHFFFAOYSA-N 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- NPFVOOAXDOBMCE-UHFFFAOYSA-N trans-3-hexenyl acetate Natural products CCC=CCCOC(C)=O NPFVOOAXDOBMCE-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229930007850 β-damascenone Natural products 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/22—Coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/186—Treatment of tobacco products or tobacco substitutes by coating with a coating composition, encapsulation of tobacco particles
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
- A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/061—Use of materials for tobacco smoke filters containing additives entrapped within capsules, sponge-like material or the like, for further release upon smoking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- Hydrogels formed as capsules, have been adapted as carrier devices for holding/delivering various molecules of interest that can be deposited within the core spaces of hydrogels.
- the molecules of interest were suspended in oil-based solvents resulting in a capsule structure comprising a hydrophobic core enclosed by a hydrophilic hydrogel matrix that can support substantial amounts of water (e.g., at least 70%).
- Such hydrogels comprising a hydrophobic core can be of limited use for many applications.
- hydrogel capsules comprising a hydrophilic core have been challenging because such capsules cannot maintain the phase separation between the hydrophilic core and the hydrophilic-hydrogel shell matrix, resulting in hydrogel capsules that exhibit sub-optimal properties, and therefore, are inadequate for long-term storage and/or prolonged usage.
- hydrogel capsules for example, comprising alginate enveloped with at least one coating layer
- Various embodiments are directed to tobacco-containing smokable and smokeless products comprising hydrogel capsules coated with at least one coating layer formulated as disclosed.
- Various embodiments are directed to tobacco-free consumer products comprising hydrogel capsules coated with at least one coating layer formulated as disclosed.
- the coating formulations deposited on the surface of hydrogel capsules can improve the physical integrity and the water-retention properties of the hydrogel capsules.
- the coating formulations can be sequentially applied in various combinations to obtain desirable properties, such as improved physical integrity, mechanical strength, and low permeability, that can extend the shelf-life of hydrogel capsules when incorporated into various consumer products.
- FIG. 1 is a schematic of a basic configuration of an hypothetical hydrogel capsule without a protective coating, which may be representative of similar structures disclosed in the prior art.
- FIG. 2 is a schematic of a hydrogel capsule protected by at least one coating layer.
- FIG. 3A is a schematic of a hydrogel capsule protected by at least one coating layer comprising a film-forming material.
- FIG. 3B is a schematic of a hydrogel capsule protected by at least one coating layer comprising a wax.
- FIG. 4 is a schematic of a hydrogel capsule protected by at least two coating layers.
- FIG. 5A is a schematic of a pouched tobacco product comprising a single hydrogel capsule protected by at least one coating layer.
- FIG. 5B is a schematic of a pouched tobacco product comprising multiple hydrogel capsules, each protected by at least one coating layer.
- FIG. 6A is an image of an exemplary alginate (Alg) hydrogel capsule coated with Eudragit® L30D-55 (a methacrylic acid-co-ethyl acrylate latex referred to herein as “Eud”) to form Eud-Alg hydrogel.
- FIG. 6B is an image of an exemplary hydrogel capsule, first coated with Eudragit® L30D-55, and coated subsequently with a wax formulation to form Wax-Eud-Alg hydrogel, as described in Example 2.
- FIGS. 7A and 7C show a cross-sectional analysis of Eud-Alg hydrogel capsule as determined by environmental scanning electron microscopy (“ESEM”).
- FIG. 7B is an EDS spectrum of Eud-Alg hydrogel capsule.
- FIGS. 7D-7F show cross-sectional analysis of Eudragit® coating to determine Ca and Na content by x-ray line scans, as described in Example 3.
- FIG. 8A shows the surface morphology of an exemplary Eud-Alg hydrogel capsule, as described in Example 4.
- FIG. 8B shows the surface morphology of an exemplary 12% ACAP-Eud-Alg hydrogel capsule, in which “ACAP” represents (acrylamidomethyl)cellulose acetate propionate, as described in Example 4.
- FIG. 8C shows the surface morphology of an exemplary Eud-Alg hydrogel capsule exposed to 120° C. for 5 min, as described in Example 4.
- FIG. 9 shows Fourier transform infrared spectroscopy (“FTIR”) graphs for various coating formulations, including a coating layer formulated with (acrylamidomethyl)cellulose acetate propionate (“ACAP”) (as graph “A”), a coating layer formulated with Eudragit® L30D-55 (“Eud”) (as graph “B”), and double-coated layers of ACAP-Eud that were sequentially deposited (as graph “C”), as described in Example 5.
- ACAP acrylamidomethylcellulose acetate propionate
- Eud Eudragit® L30D-55
- C double-coated layers of ACAP-Eud that were sequentially deposited
- FIG. 10 shows differential scanning calorimetry (“DSC”) graphs for various coating formulations, including a coating layer formulated with Eudragit® L30D-55 (as curve “Eud”), a coating layer formulated with (acrylamidomethyl)cellulose acetate propionate (as curve “ACAP”), and double-coated layers of ACAP-Eud that were sequentially deposited (as curve “ACAP-Eud”), as described in Example 6.
- DSC differential scanning calorimetry
- FIG. 11 shows water-retention profiles, expressed as % weight retention, for various hydrogels tested, including alginate hydrogel capsules (“Alg Bead”), Eud-coated alginate hydrogel capsules (“Eud-Alg Bead”), alginate hydrogel capsules coated with 12% ACAP-Eud (“12% ACAP-Eud-Alg Bead”), and alginate hydrogel capsules coated with 24% ACAP-Eud-Alg (“24% ACAP-Eud-Alg Bead”) respectively, measured at room conditions of 23° C. and RH 50%, as described in Example 7.
- Alg Bead alginate hydrogel capsules
- Eud-Alg Bead Eud-coated alginate hydrogel capsules
- alginate hydrogel capsules coated with 12% ACAP-Eud 12% ACAP-Eud-Alg Bead
- alginate hydrogel capsules coated with 24% ACAP-Eud-Alg
- FIG. 12 shows short-term (5 hours) and long-term (3 days) water-retention profiles, expressed as % weight retention, for Eud-coated alginate hydrogel capsules that were exposed to different pH conditions after coating with Eudragit®, measured at 23° C. and RH 50%, as described in Example 8.
- FIG. 13A shows the effect on the surface morphology of Eud-Alg hydrogel capsules exposed to pH 1.6 condition after coating with Eudragit®, as described in Example 8.
- FIG. 13B shows the effect on the surface morphology of Eud-Alg hydrogel capsules exposed to pH 4.6 condition after coating with Eudragit®, as described in Example 8.
- FIG. 14 shows short-term (5 hours) and long-term (3 days) water-retention profiles, expressed as % weight retention, for Eud-coated alginate hydrogel capsules that were exposed to different thermal exposure after coating with Eudragit®, measured at 23° C. and RH 50%, as described in Example 9.
- FIG. 15 shows water-retention profiles, expressed as % weight retention, for ACAP-Eud-coated alginate hydrogel capsules that were exposed to 60° C. for 10 min, after coating with Eudragit®, measured at 23° C. and RH 50%, as described in Example 9.
- FIG. 16A shows the surface morphology of ACAP-Eud-Alg hydrogel capsules not exposed to heat, as described in Example 9.
- FIG. 16B shows the surface morphology of ACAP-Eud-Alg hydrogel capsules exposed to 60° C. for 10 min, as described in Example 9.
- FIG. 17 shows water-retention profiles, expressed as % weight retention, for various combinations of coating formulations deposited on the surface of alginate hydrogel capsules, measured at room conditions 23° C. and RH 50%, as described in Example 10.
- a core includes a plurality of such cores
- a reference to “the hydrogel capsule” includes reference to one or more of such hydrogel capsules.
- hydrogel refers to any network of polymer chains crosslinked together for stabilization, and is amenable to shaping into a desirable form (e.g., spherical, disk, elliptical, pod-like). Hydrogels include colloidal gels that can hold substantial amounts of water. Alginate is a preferred hydrogel. Other hydrogels include pectins and carrageenan.
- capsule refers to a structure comprising at least one continuous surface of a material enclosed together to form at least one core in the interior space of the capsule.
- the terms capsule and bead are used interchangeably herein.
- the capsule comprises a single core, sufficient to carry a molecule of interest or a combination of molecules of interest.
- hydrophilic refers to a charge-polarized molecule that, via hydrogen bonding, can associate more readily with water (or dissolve more readily in water) than with (or in) oil or other hydrophobic solvents. Hydrophilic molecules are typically positively or negatively charged, or zwitterionic, and include solute molecules and solvent molecules. Examples of hydrophilic molecules include water molecules, colloids, and any water-soluble molecules, such as alcohols.
- hydrophobic refers to a neutrally-charged molecule, and includes non-polar solute molecules and non-polar solvent molecules. In water, hydrophobic molecules can cluster together to form micelles. Examples of hydrophobic molecules include alkanes, oils, and fats.
- coating or “coating layer” or “film” or “film layer” are interchangeably used.
- a coating layer may be deposited onto the surface of hydrogel capsules.
- a coating layer may be deposited onto the surface of another coating layer, in which case the “first” coating layer is applied before the “second” coating layer.
- tobacco refers to any variety of the genus Nicotiana , and includes native tobacco variants, transgenic tobacco variants, and cultured tobacco grown in vitro.
- Exemplary species of tobacco include N. rustica, N. tabacum (e.g., LA B21, LN KY171, TI 1406, Basma, Galpao, Perique, Beinhart 1000-1, and Petico).
- Other species include N. acaulis, N. acuminata, N. acuminata var. multiflora, N. africana, N. alata, N. amplexicaulis, N. arentsii, N. attenuata, N. benavidesii, N. benthamiana, N.
- N. occidentalis N. occidentalis subsp. hesperis, N. otophora, N. paniculata, N. pauciflora, N. petunioides, N. plumbaginifolia, N. quadrivalvis, N. raimondii, N. repanda, N. rosulata, N. rosulata subsp. ingulba, N. rotundifolia, N. setchellii, N. simulans, N. solanifolia, N. spegazzinii, N. stocktonii, N. suaveolens, N. sylvestris, N. thyrsiflora, N. tomentosa, N.
- the tobacco may be whole, shredded, cut, cured, aged, fermented, or otherwise processed, e.g., granulated or encapsulated.
- Tobacco may also be in the form of finished products, including any non-combustible tobacco that can be orally consumed, e.g., smokeless tobacco and lit-end smokable products, such as cigars and cigarettes.
- FIG. 1 is a schematic of a basic configuration of a hypothetical hydrogel capsule without a protective coating, which may be representative of similar structures disclosed in the prior art.
- the hydrogel capsule 100 comprises a core component (“core”) 110 enclosed by a hydrogel matrix (“shell”) 120 . If molecules of interest are suspended in a hydrophobic solvent (e.g., oil) and deposited within the core 110 of the capsule, then the capsule is more likely to retain the initial physical integrity/shape defined at the time of manufacture due to inherent repulsive forces between the “hydrophobic” core and the “hydrophilic” shell.
- a hydrophobic solvent e.g., oil
- hydrophilic e.g., water
- the physical integrity/shape of the capsule is more likely to deviate substantially from the initial state (i.e., defined at the time of manufacture).
- the physical boundary between the hydrophilic core and the hydrophilic shell become less-defined.
- a hydrogel capsule comprising a hydrophilic core may be unsuitable to carry unstable molecules that are more likely to be inactivated (e.g., precipitation or aggregation of molecules of interest) if the concentration of these molecules increases due to water loss via evaporation.
- improvements in the manufacture of both types of hydrogel capsules are highly desirable.
- Hydrogel capsules can be incorporated into various consumable products, including: (a) tobacco-containing products, such as (i) smoking tobacco products and (ii) smokeless tobacco products; and (b) consumable products without tobacco. Other uses include controlled release of active agents (such as nutraceuticals, water soluble flavors or drugs), cell immobilization, cell delivery, or cell storage.
- active agents such as nutraceuticals, water soluble flavors or drugs
- Coating formulations can be employed in the manufacture of: (a) hydrogel capsules comprising a hydrophilic core, and (b) hydrogel capsules comprising a hydrophobic core, although the examples may be described in the context of hydrogel capsules of type (a).
- the coating formulations can be sequentially applied in various combinations to obtain desirable properties. For example, the physical integrity, the mechanical strength, and the capacity for water retention of the capsules can be controlled.
- the improved shell/coating structure disclosed herein can overcome problems such as undesired swelling and dissolving of alginate capsules, thereby improving the shelf-life of the capsules, which is helpful for their incorporation into various consumer products.
- FIG. 2 is a schematic of a hydrogel capsule protected by at least one coating layer.
- an exemplary hydrogel capsule 200 is shown, comprising: a core 210 , a hydrogel matrix/shell 220 , and one coating layer 230 that envelops the exterior surface of the hydrogel matrix/shell 220 .
- the coating layer 230 can serve as a protective layer or a protective film to maintain or to strengthen the physical integrity of the hydrogel capsule.
- the coating layer 230 can reduce the permeability of the hydrogel capsule by serving as a physical barrier that can prevent the diffusion of water molecules from the exterior surface of the hydrogel matrix/shell 220 .
- FIGS. 6A , 8 A, 8 C, 13 A, and 13 B illustrate the effectiveness of depositing Eudragit® as a coating layer for protecting alginate hydrogel capsules as determined by optical imaging or surface morphology analysis.
- Various molecules of interest can be included as additive components of the core within the hydrogel capsules, including various flavor agents, sensates, sequestering agents, coloring agents, plasticizing agents, complexing agents, filling agents, natural and/or artificial sweeteners, binders, thickening agents, souring agents, pigments, surfactants, stabilizing agents, antioxidants, preservatives, humectants, medicaments, tobacco, tobacco extracts, equivalents, and other additives as described below.
- controlled-release refers to the capacity to control the release profile of an encapsulation device, such as hydrogel capsules described herein. Any of these components can be encapsulated individually, or as a combination, into smaller capsules in order to control the release profile for any component as desired. For example, if a fast-release profile is desired for a first flavorant of interest, then the porosity of the polymer constituting the capsules can be increased. In contrast, if a slow-release profile is desired for a second flavorant of interest, then the porosity of the polymer constituting the capsules can be decreased.
- Suitable flavorants which may generate taste and/or aroma, include any natural or synthetic flavorant, such as tobacco, smoke, menthol, mint, such as peppermint and spearmint, chocolate, licorice, citrus and other fruit flavorants, gamma octalactone, vanillin, ethyl vanillin, breath freshener flavorants, spice flavorants such as cinnamon, methyl salicylate, linalool, bergamot oil, geranium oil, lemon oil, and ginger oil.
- Other suitable flavorants may include flavorant compounds selected from the group consisting of an acid, an alcohol, an ester, an aldehyde, a ketone, a pyrazine, combinations thereof and equivalents.
- Suitable flavorant compounds may be selected, for example, from the group consisting of phenylacetic acid, solanone, megastigmatrienone, 2-heptanone, benzylalcohol, cis-3-hexenyl acetate, valeric acid, valeric aldehyde, ester, terpene, sesquiterpene, nootkatone, maltol, damascenone, pyrazine, lactone, anethole, iso-valeric acid, combinations thereof and equivalents.
- flavorants can also be encapsulated for controlled delivery.
- Exemplary additional natural and artificial flavorants include peppermint, spearmint, wintergreen, menthol, cinnamon, chocolate, vanillin, licorice, clove, anise, sandalwood, geranium, rose oil, vanilla, lemon oil, cassia, spearmint, fennel, ginger, ethylacetate, isoamylacetate, propylisobutyrate, isobutylbutyrate, ethylbutyrate, ethylvalerate, benzylformate, limonene, cymene, pinene, linalool, geraniol, citronellol, citral, peppermint oil, orange oil, coriander oil, borneol, fruit extract, and equivalents.
- flavorant agents include essential oils and essences of coffee, tea, cacao, and mint.
- a suitable amount of a flavorant present in the core ranges from about 0.001 wt % to about 50 wt %. In a preferred embodiment, the amount ranges from about 1 wt % to about 40 wt %. In a preferred embodiment, the amount ranges from about 10 wt % to about 30 wt %.
- the flavorant may be incorporated as a solid powder, sprayed dried as a liquid, or mixed with starch or gum-type matrix.
- Sensates are ingredients that can induce a sensorial experience, such as tingling, sensation of warmth, sensation of cooling, and equivalents.
- Suitable sensates include sensate agents such as acetic acid, adipic acid, citric acid, lactic acid, maleic acid, succinic acid, tartaric acid, equivalents and mixtures thereof.
- a suitable amount of a sensate agent ranges from about 0.001 wt % to about 5 wt %. In a preferred embodiment, the amount of sensate agent ranges from about 0.1 wt % to about 2 wt %.
- sequestering agents can be employed for binding components of tobacco or tobacco extracts, such as tobacco-specific nitrosamines (“TSNAs”) within the core of the hydrogel capsule.
- Sequestering agents can be effective in reducing the diffusion or transport of certain TSNAs from various tobacco-containing products (e.g., pouched products) into a consumer's mouth.
- Suitable sequestering agents include polyvinylpolypyrrolidone.
- a suitable amount of sequestering agent ranges from 0.001 up to about 5 wt %, and more preferably ranges up to about 2 wt %.
- the capsules can optionally include antioxidants and/or preservatives.
- antioxidants include ascorbic acid, vitamin E, and sodium pyrosulfate.
- preservatives include acetic acid, benzoic acid, citric acid, lactic acid, malic acid, sorbic acid, and tartaric acid.
- a suitable amount of an antioxidant and/or preservative ranges from 0.001 up to about 5 wt %, and more preferably ranges up to about 2 wt %.
- the capsules can include a tobacco component. Any raw or processed forms of tobacco, e.g., as a powder/dust, a granule, a shred, a slurry, a flowable gel, and equivalents can be added to the capsules.
- the final tobacco concentration in the capsules ranges from 1 percent to 99 percent by weight of the final composition, for example, and ranges at most from about 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, or 90% tobacco.
- the alginate capsules include about 20 to 30% tobacco.
- Humectants can be employed for maintaining and protecting the moisture levels of the tobacco material in tobacco-containing hydrogel capsules. Humectants can be employed as preservatives to remove excess water and thereby, reduce the growth of micro-organisms. Humectants can be employed for providing a higher moisture feel in a drier tobacco material (or tobacco substitute material) or a drier smokeless tobacco material. Examples of humectants include glycerol and propylene glycol. A suitable amount of a humectant ranges from about 0.001 wt % to about 5 wt %. More preferably, the amount ranges from about 0.1 wt % to about 2 wt %.
- Exemplary binders include mono based or polysaccharide based materials, modified cellulosics, starches, and/or cellulose ethers.
- a suitable amount of a binder ranges from 0.001 up to about 20 wt %, and more preferably the amount ranges up to about 10 wt %.
- Exemplary thickening agent include polymers such as polyvinyl pyrrolidone and polyvinyl alcohol, and gums such as xanthan gum, gum arabic, and acacia gum.
- the stiffness of capsules can be increased and the dissolution rate (i.e., dissolution upon exposure to moisture) can be decreased by increasing the average molecular weight of polymers that form a film.
- Thickening agents can be added to the core of the capsules to increase the modulus (i.e., stiffness) of the capsules and to reduce the deformation of capsules during/after the drying step (e.g., during storage).
- a suitable thickening agent ranges from 0.001 up to about 20 wt. %, and more preferably ranges from 0.001 up to about 5 wt. % of the final dried composition.
- the capsules can optionally contain medicaments, nutraceuticals, and/or cosmetics. Examples thereof include vitamins, perfumes, and ointments.
- the capsules can optionally contain products not intended for human consumption, for example agrochemicals, disinfectants, detergents, and dyestuff.
- Filling agents can be employed for controlling the physical properties of the hydrogel capsule (e.g., texture, weight, etc.).
- Exemplary filling agents include cellulose, titanium oxide, magnesium silicate (e.g., talc), aluminum silicate, magnesium carbonate, calcium carbonate (e.g., limestone), calcium phosphate, calcium sulfate, zinc oxide, aluminum oxide, equivalents, equivalents, and mixtures thereof.
- Filling agents such as carbonate and phosphate salts can also be used to adjust the pH.
- the pH of the capsules is greater than 5, more preferably greater than 6 (e.g., greater than 6.5, 7, or 7.5).
- the filling agents can be incorporated in an amount up to about 50 wt. %.
- Suitable natural and/or artificial sweeteners include water soluble sweeteners such as monosaccharides, disaccharides, and polysaccharides (e.g., xylose, ribose, sucrose, maltose, fructose, glucose, maltose, mannose).
- a suitable amount of a sweetener ranges from about 0.001 wt % to about 5 wt %. In a preferred embodiment, the amount of a sweetener ranges from about 0.1 wt % to about 2 wt %.
- Plasticizing agents can be employed for controlling the stiffness and the viscosity of a polymer melt during casting or extrusion.
- Exemplary plasticizing agents include monoacetin; diacetin; triacetin; glycols such as polyethylene glycol and propylene glycol; polyhydric alcohols such as glycerin and sorbitol; mineral oils; vegetable oils; glycerol and glycerol esters such as glycerol triacetate.
- a suitable amount of a plasticizing agent ranges from 0.001 up to about 20 wt. %, and more preferably ranges up to about 5 wt. %.
- Exemplary stabilizing agents include various gums such as guar gum, xanthan gum, locust bean gum, and carrageenan.
- a suitable amount of a stabilizing agent ranges from 0.001 up to 10 wt. %, and more preferably ranges up to about 2 wt. % of the final composition.
- Suitable surfactants include mono and diglycerides of fatty acids, lactylates, pluronic acid, polyoxyethylene sorbitol esters, latanol, sodium lauryl sulfate, and equivalents.
- a suitable amount of surfactants ranges from 0.001 up to about 10 wt. %, and more preferably ranges up to about 2 wt. % of the final composition.
- Suitable pigments or coloring agents can be incorporated in an amount from 0.001 up to about 5 wt. % of the final composition.
- suitable crosslinkable polymers include alginates, pectins, carrageenan, and equivalents thereof.
- An exemplary formulation for producing an alginate hydrogel is provided in Example 1.
- the various components suitable for incorporation into the core component can be suitable for incorporation into the hydrogel matrix/shell (e.g., flavorants, pigments).
- a crosslinked polymer can be obtained by various methods, including by ionic gelation, in which ions are added to a suspension of the monomers of a suitable polymer.
- ions suitable to activate ionic gelation include, sodium, potassium, calcium, aluminum, lanthanum, magnesium, and barium.
- a suitable amount of a polymer ranges in an amount up to about 95 wt %, more preferably from about 0.5 wt % to about 85 wt %, and most preferably from about 10 wt % to about 75 wt % based on the total weight of hydrogel matrix/shell.
- the rate of diffusion of components contained in the core can be controlled by adjusting the thickness and/or porosity of the matrix/shell.
- the porosity of matrix/shell i.e., crosslinking density
- M:G mannuronic units to guluronic units
- the mannuronic:guluronic ratio should be greater than 1:1, and the ratio may range from about 1.5-3:1.
- the mannuronic:guluronic ratio should be less than 1:1, and the ratio may range from about 0.4:1-0.6:1.
- FIGS. 3A , 3 B, and 4 provide exemplary coating configurations that have been described further in Examples 1-10.
- the various components suitable for incorporation into the core component can be suitable for incorporation into a coating layer (e.g., flavorants, pigments, souring agents).
- FIG. 3A is a schematic of a hydrogel capsule protected by at least one coating layer comprising a film-forming material.
- an exemplary hydrogel capsule 300 is shown, comprising: a core 310 comprising one or more components as described herein, a hydrogel matrix/shell 320 of one or more polymer materials as described herein, and one coating layer 330 of one or more coating materials as described herein that envelops the exterior surface of the hydrogel matrix/shell 320 .
- a hydrogel capsule comprises: a core; a hydrogel matrix/shell; and a coating layer such as a film-forming latex that completely envelops the exterior surface of the hydrogel matrix/shell.
- a hydrogel capsule may comprise: a core that includes at least one core component such as a flavorant and/or sensate; a hydrogel matrix/shell; and a coating layer comprising a film-forming latex that completely envelops the exterior surface of the hydrogel matrix/shell.
- a tobacco-containing hydrogel capsule comprises: a core that includes tobacco and/or tobacco extract; a hydrogel matrix/shell selected from the group consisting of alginates, pectins, and carrageenan; and a single coating layer selected from the group consisting of Eudragit® L30D-55 and (acrylamidomethyl)cellulose acetate propionate (ACAP).
- ACAP acrylamidomethylcellulose acetate propionate
- a tobacco-containing hydrogel capsule comprising: a core that includes tobacco, tobacco extract, and/or a sequestration agent; a hydrogel matrix/shell selected from the group consisting of alginates, pectins, and carrageenan; and a single coating layer selected from the group consisting of Eudragit® L30D-55 and (acrylamidomethyl)cellulose acetate propionate (ACAP).
- a tobacco-containing hydrogel capsule comprising: a core that includes tobacco, tobacco extract, and/or a sequestration agent; a hydrogel matrix/shell selected from the group consisting of alginates, pectins, and carrageenan; and a single coating layer selected from the group consisting of Eudragit® L30D-55 and (acrylamidomethyl)cellulose acetate propionate (ACAP).
- ACAP acrylamidomethylcellulose acetate propionate
- FIG. 3B is a schematic of a hydrogel capsule protected by at least one coating layer comprising a wax.
- an exemplary hydrogel capsule 350 is shown, comprising: a core 360 comprising one or more components as described herein, a hydrogel matrix/shell 370 of one or more polymer materials as described herein, and a single coating layer 380 of one or more coating materials as described herein that envelops the exterior surface of the hydrogel matrix/shell 370 .
- a hydrogel capsule comprises: a core; a hydrogel matrix/shell; and a single coating layer comprising a wax that completely envelops the exterior surface of the hydrogel matrix/shell.
- a hydrogel capsule comprises: a core that includes at least one flavorant and/or sensate; a hydrogel matrix/shell; and a single coating layer comprising a wax that completely envelops the exterior surface of the hydrogel matrix/shell.
- a tobacco-containing hydrogel capsule comprises: a core that includes tobacco and/or tobacco extract; a hydrogel matrix/shell selected from the group consisting of alginates, pectins, and carrageenan; and a single coating layer selected from the group consisting of paraffin wax, carnauba wax, and polyester wax.
- a tobacco-containing hydrogel capsule comprising: a core that includes tobacco, tobacco extract, and/or a sequestration agent; a hydrogel matrix/shell selected from the group consisting of alginates, pectins, and carrageenan; and a single coating layer selected from the group consisting of paraffin wax, carnauba wax, and polyester wax.
- FIG. 4 is a schematic of a hydrogel capsule protected by at least two coating layers.
- an exemplary hydrogel capsule 400 is shown, comprising: a core 410 comprising one or more components as described herein, a hydrogel matrix/shell 420 of one or more polymer materials as described herein, a first coating layer 430 of one or more coating materials as described herein that envelops the exterior surface of the hydrogel matrix/shell 420 , and a second coating layer 440 of one or more coating materials as described herein that envelops the exterior surface of the hydrogel matrix/shell 430 .
- a hydrogel capsule comprising: a core; a hydrogel matrix/shell; a first coating layer comprising a first film-forming material that envelops the exterior surface of the hydrogel matrix/shell; and a second coating layer comprising a second film-forming material that envelops the exterior surface of the first coating layer.
- a hydrogel capsule comprising: a core that includes at least one flavorant and/or sensate; a hydrogel matrix/shell such as alginate, pectin and/or carrageenan; a first coating layer comprising a first film-forming material that envelops the exterior surface of the hydrogel matrix/shell; and a second coating layer comprising a second film-forming material such as a wax or latex film that envelops the exterior surface of the first coating layer.
- a hydrogel capsule comprises: a core; a hydrogel matrix/shell selected from the group consisting of alginates, pectins, and carrageenan; a first coating layer comprising a first film-forming material that envelops the exterior surface of the hydrogel matrix/shell; and a second coating layer selected from the group consisting of paraffin wax, carnauba wax, and polyester wax.
- a tobacco-containing hydrogel capsule comprises: a hydrogel capsule comprising: a core that includes tobacco and/or tobacco extract and optionally a sequestration agent, flavorant and/or sensate; a hydrogel matrix/shell; a first coating layer comprising a film-forming material that envelops the exterior surface of the hydrogel matrix/shell; and a second coating layer comprising a wax that envelops the exterior surface of the first coating layer.
- smokeless tobacco products comprising at least one hydrogel capsule as described throughout this disclosure.
- smokeless tobacco products include snuff (moist or dry), chewing tobacco, loose tobacco, pouched tobacco, and equivalents.
- the disclosed smokeless tobacco products have a number of advantages, including longer shelf-life, improved taste, improved sensorial experience, and prolonged enjoyment in the use of such products due to the encapsulation of tobacco and other components. Tobacco and tobacco extracts can be interchangeably utilized.
- hydrogel capsules that can be incorporated into various smokeless pouched tobacco products can vary substantially.
- FIGS. 5A-5D provide examples of such products.
- FIG. 5A is a schematic of a pouched tobacco product comprising a single hydrogel capsule protected by at least one coating layer.
- the pouch product 500 comprises: a porous membrane 510 that encloses a single hydrogel capsule 512 comprising a hydrogel matrix/shell 516 that encloses a core 514 that includes a tobacco material, a flavorant, a sensate, and/or a sequestration agent.
- the tobacco material can be further encapsulated.
- FIG. 5B is a schematic of a pouched tobacco product comprising multiple hydrogel capsules, each protected by at least one coating layer.
- the pouch product 520 comprises: a porous membrane 522 that encloses multiple hydrogel capsules, such as 524 and 526 , wherein each hydrogel capsule comprising a hydrogel matrix/shell that encloses a core that includes a tobacco material, a flavorant, a sensate, and/or a sequestration agent.
- smokable tobacco products comprising at least one hydrogel capsule as described throughout this disclosure.
- the disclosed smokable tobacco products have a number of advantages, including longer shelf-life, improved taste, improved sensorial experience, and prolonged enjoyment in the use of such products due to the encapsulation of tobacco and other components. Tobacco and/or tobacco extracts can be utilized.
- the hydrogel capsules can be incorporated into the filters of various smoking products, such as cigars and cigarettes.
- the smoking articles have a longer shelf-life because the volatile flavors and sensates can be stabilized within the core of the capsules, due to at least one coating later that reduces the permeability of the hydrogel capsule.
- the composition of the hydrogel matrix can be modified in order to obtain a desirable flavorant-release profile.
- Various embodiments are directed to tobacco-free consumer products comprising at least one hydrogel capsule as described throughout this disclosure.
- Alginate hydrogel capsules impregnated with water molecules can be formed by cross-linking together alginate polymer chains in a reaction mediated by Ca 2+ ions that can enter the electronegative, inter-chain cavities of the alginate polysaccharide promoting the formation of rod-like, cross-linked matrix structure.
- 4-5 mm diameter alginate hydrogel capsules were formed by reacting together 2% sodium alginate aqueous solution at pH 7.7 and 5% CaCl 2 solution at pH 7.0.
- a transfer pipette (with an opening of approximately 4 mm in diameter) was used to dispense 25 ml of 2% sodium alginate aqueous solution as droplets into 30 ml of 5% CaCl 2 solution.
- the mixture was stirred using a magnetic stirrer at 260 rpm for 30 seconds to form water-impregnated alginate hydrogel capsules (Alg) with a diameter of approximately 4 mm.
- the hydrogel capsules were then transferred into 200 ml of distilled water and stirred using a magnetic stirrer at 260 rpm for 3 min to stop the alginate cross-linking reaction with the calcium ions.
- These cross-linked hydrogel capsules contained approximately 97% water content by weight, and exhibited sufficient structural integrity to be subjected to subsequent coating steps with various polymers and/or wax, as described below.
- each coating layer was sequentially deposited over alginate hydrogel capsules according to the following procedure.
- Ten alginate hydrogel capsules were placed into 10 ml of a 30% aqueous dispersion of Eudragit® (“Eud”) and were shaken gently for 30 seconds.
- the Eud-coated alginate hydrogel capsules (“Eud-Alg”) were then physically separated from the aqueous medium using a sieve.
- a second coating was obtained by immersing Eud-Alg hydrogel capsules into a 12% ACAP solution (12% ACAP-Eud-Alg hydrogel capsules), or a 24% ACAP solution (24% ACAP-Eud-Alg hydrogel capsules), in acetone with castor oil (3% w/v), respectively, for 10 seconds.
- These double-coated hydrogel capsules (“ACAP-Eud-Alg”) were then separated from the solution using a sieve. Both of these concentrations produced workable viscosities.
- Castor oil (3% w/v) was added to each solution to prevent the hydrogel capsules from adhering to each other.
- Acetone may be employed for facilitate the rate of evaporation during ACAP layer formation at room temperature.
- hydrogel capsules protected with two coating layers in which one coating layer comprises a wax formulation: 1) Eud-Alg hydrogel capsules were placed in a dry-ice-acetone bath for 1 min; 2) the frozen Eud-Alg hydrogel capsules were placed into molten wax and were shaken for 5 seconds; and 3) the wax-coated hydrogel capsules (“Wax-Eud-Alg”) were collected on filter paper and cooled to room temperature.
- one coating layer comprises a wax formulation: 1) Eud-Alg hydrogel capsules were placed in a dry-ice-acetone bath for 1 min; 2) the frozen Eud-Alg hydrogel capsules were placed into molten wax and were shaken for 5 seconds; and 3) the wax-coated hydrogel capsules (“Wax-Eud-Alg”) were collected on filter paper and cooled to room temperature.
- alginic acid sodium salt from brown algae, with the viscosity of a 2% solution at 25° C. being ⁇ 250 cps; (acrylamidomethyl)cellulose acetate propionate (ACAP), average M n ⁇ 20,000 by GPC; carnauba wax, refined, No. 1 yellow (melting point 83° C. to 86° C.); granular paraffin waxes (melting points ranging from 48° C. to 74° C.) available from Sigma-Aldrich (Sigma-Aldrich Corporation, St. Louis, Mo. 63103 USA); Eudragit® L30D-55 (Eud), Mw approx.
- Alg alginic acid sodium salt
- ACAP acrylamidomethylcellulose acetate propionate
- FIG. 6A is an image of an exemplary alginate hydrogel capsule coated with Eudragit® L30D-55 to form Eud-Alg hydrogel.
- FIG. 6B is an image of an exemplary hydrogel capsule, which is first coated with Eudragit® L30D-55, and coated subsequently with a wax formulation to form Wax-Eud-Alg hydrogel. Each image contains a scale showing distance in mm.
- Eudragit® L30D-55 was deposited onto the surface of alginate hydrogel capsules by immersing freshly prepared alginate hydrogel capsules into an aqueous dispersion of Eudragit® at a pH of 2.5-3.5. Under visual examination, the surface of these Eud-Alg hydrogel capsules appeared smooth and uniform.
- FIGS. 7A and 7C show a cross-sectional analysis of Eud-Alg hydrogel capsule as determined by ESEM.
- both the core of the alginate hydrogel matrix and the Eudragit® coating layer demonstrated shrinkage after exposure to a vacuum during sample preparation for ESEM analysis, generating an artifactual void between the alginate hydrogel matrix shell and the Eudragit® coating layer.
- the Eudragit® coating layer demonstrated significant mechanical integrity by not collapsing or fracturing in response to the shrinkage of alginate core.
- the cross-sectional thickness of Eudragit® coating layer was determined to be about 200 ⁇ m.
- the Eudragit® coating layer also contained Na and Ca, and a band rich in Na and Ca appeared to be present about 125 ⁇ m from the interior surface of the Eudragit® coating layer (arrow).
- FIG. 7B is an energy dispersive spectrum (“EDS”) of an Eud-Alg hydrogel capsule.
- EDS energy dispersive spectrum
- FIGS. 7D-7F show cross-sectional analysis of Eudragit® coating to determine Ca and Na content by x-ray line scans.
- the cross-sectional thickness of the Eudragit® coating layer was determined by cross cutting the Eud-Alg hydrogel capsules with a razor blade. The cross cut hemispheres were then placed with the cut face up, onto a 25.4 mm diameter carbon adhesive disk attached to a 32 mm diameter aluminum stub.
- Cross sections were imaged using an FEI XL30 Environmental Scanning Electron Microscope (ESEM) operating at 15 to 20 kV in H 2 O vapor mode at a pressure of 0.1 to 1.1 torr.
- Selected area elemental analyses were performed on the uncoated cross sections using the EDAX energy dispersive spectrometer (EDS) interfaced with the EDAX Genesis software. X-ray line scans were also generated over the freshly-cut cross sections on the copolymer shells.
- FIG. 8A shows the surface morphology of Eud-Alg hydrogel capsules.
- the surface of the Eudragit® coating layer appeared to be rough and textured displaying random arrays of submicron pores, less than 3 ⁇ m throughout the samples. Some surface particles appeared to blend into the surface of the Eudragit® coating layer.
- FIG. 8B shows the surface morphology of 12% ACAP-Eud-Alg hydrogel capsules, in which “ACAP” represents (acrylamidomethyl)cellulose acetate propionate.
- ACAP represents (acrylamidomethyl)cellulose acetate propionate.
- the surface of the ACAP coating layer contained an array of circular indentations, or pits. These surface phenomena may have been formed by the fast rate of acetone evaporation from the ACAP coating layer at room temperature.
- FIG. 8C shows the surface morphology of thermally treated Eud-Alg hydrogel capsules exposed to 120° C. for 5 min.
- the surface of the Eud-Alg hydrogel capsules appeared to be smoother after exposure to 120° C. for 5 min, when compared to the surface appearance of 12% ACAP-Eud-Alg hydrogel capsules as shown in FIG. 8B .
- FIG. 9 shows FTIR graphs for various coating formulations, including a coating layer formulated with (acrylamidomethyl)cellulose acetate propionate (“ACAP”) (as graph “A”), a coating layer formulated with Eudragit® L30D-55 (“Eud”) (as graph “B”), and double-coated layers of ACAP-Eud that were sequentially deposited (as graph “C”).
- ACAP acrylamidomethylcellulose acetate propionate
- Eud Eudragit® L30D-55
- C double-coated layers of ACAP-Eud that were sequentially deposited
- Curve C is a spectrum from the ACAP-Eud coating on alginate hydrogel capsules, and shows the presence of both Eudragit®-specific and ACAP-specific peaks: 1629, 805 cm ⁇ 1 (C ⁇ C stretching), 1177 cm ⁇ 1 (C—CO—C— stretching), 1383 cm ⁇ 1 (CH 3 — asymmetric bending).
- the shift of C—CO—C— stretching from 1160 cm ⁇ 1 to 1177 cm ⁇ 1 may be indicative of complex formation or hydrogen bonding between ACAP and Eudragit®.
- FTIR Fourier transform infrared spectroscopy
- FIG. 10 shows DSC graphs for various coating formulations, including a coating layer formulated with Eudragit® L30D-55 (as curve “Eud”), a coating layer formulated with (acrylamidomethyl)cellulose acetate propionate (as curve “ACAP”), and double-coated layers of ACAP-Eud that were sequentially deposited (as curve “ACAP-Eud”).
- ACAP acrylamidomethylcellulose acetate propionate
- ACAP-Eud double-coated layers of ACAP-Eud that were sequentially deposited
- T g glass transition temperature
- DSC Differential scanning calorimetry
- FIG. 11 shows water-retention profiles, expressed as % weight retention, for various hydrogels tested, including alginate hydrogel capsules (“Alg Bead”), Eud-coated alginate hydrogel capsules (“Eud-Alg Bead”), alginate hydrogel capsules coated with 12% ACAP solution (“12% ACAP-Eud-Alg Bead”), and alginate hydrogel capsules coated with 24% ACAP solution (“24% ACAP-Eud-Alg Bead”) respectively, measured at room conditions of 23° C. and RH 50%.
- Alg Bead alginate hydrogel capsules
- Eud-Alg Bead Eud-coated alginate hydrogel capsules
- alginate hydrogel capsules coated with 12% ACAP solution 12% ACAP-Eud-Alg Bead
- alginate hydrogel capsules coated with 24% ACAP solution 24% ACAP solution
- FIG. 12 shows short-term (5 hours) and long-term (3 days) water-retention profiles, expressed as % weight retention, for Eud-coated alginate hydrogel capsules that were exposed to different pH conditions after coating with Eudragit®, measured at 23° C. and RH 50%.
- the pH effect on Eud-Alg hydrogel capsules was tested by immersing hydrogel capsules into buffer solutions at various pH values of 1.6, 2.4, 3.4, 4.6, and 7.0, respectively, at room temperature for 10 seconds.
- Eudragit® is a pH-dependent, film-forming material that can dissolve in water at pH over 5.5.
- the Eud-Alg hydrogel capsules were subsequently immersed in HOAc/NaOAc buffer solutions having pH values ranging from 1.6 to 7.0. Generally, as the buffer solution is increased in pH, the % of water retention by the hydrogel capsules decreases. For example, at the pH of 1.6, the Eud-Alg hydrogel capsules exhibited 40% water retention after three days. In contrast, at the pH of 4.6, the Eud-Alg hydrogel capsules exhibited 18% at a comparable time point.
- the pH effect on the water retention capacity of Eud-Alg hydrogel capsules can be the result of changes in the degree of ionization for both Eudragit® and alginate under different pH conditions.
- the degree of ionization of Eudragit® can change significantly between pH 2.4 and 7.0. Moreover, the degree of ionization of alginate (pKa around 4) can also change in this pH range. At a low pH, Eudragit® ionization decreases. The non-ionized chains of Eudragit® tend to form a tighter network, which results in reduced water permeability. At a higher pH value, the Eudragit® coating can progressively ionize and undergo swelling so that water permeability increases, resulting in water loss. The data suggests that exposing Eud-Alg hydrogel capsules to low pH conditions can improve their water retention properties.
- FIG. 13A shows the effect on the surface morphology of Eud-Alg hydrogel capsules exposed to pH 1.6 condition after coating with Eudragit®. At pH value of 1.6, the coating layer exhibited tight surface tension resulting in a lower rate of water loss.
- FIG. 13B shows the effect on the surface morphology of Eud-Alg hydrogel capsules exposed to pH 4.6 condition after coating with Eudragit®. At pH value of 4.6, the coating layer appeared to be partially eroded resulting in a higher rate of water loss.
- FIG. 14 shows short-term (5 hours) and long-term (3 days) water-retention profiles, expressed as % weight retention, for Eud-coated alginate hydrogel capsules that were exposed to different thermal exposure after coating with Eudragit®, measured at 23° C. and RH 50%.
- FIG. 14 higher % water retention within the Eud-Alg hydrogel capsules was observed for capsules treated at higher temperatures. Heat exposure at 120° C. for 5 min was the most effective temperature/duration tested, in that the water retention was 75% after 5 hours of aging, and about 59% after 3 days of aging.
- the % water retention of the 24% ACAP-Eud-coated alginate hydrogel capsules after heat exposure at 60° C. for 10 min was 56% after 5 hours, and 51% after 3 days, measured at 23° C. and 50% RH.
- FIG. 15 shows water-retention profiles, expressed as % weight retention, for ACAP-Eud-coated alginate hydrogel capsules that were exposed to 60° C. for 10 min, after coating with Eudragit®, measured at 23° C. and RH 50%. The % water retention decreased to 35% after 3 weeks of exposure at room conditions.
- Table 1 below shows the effect of heat exposure on water retention properties, expressed as % water loss by weight, for Eudragit® coating formulations deposited on the surface of alginate hydrogel capsules.
- the percentage of water retained in the various Eud-Alg hydrogel capsules after heat exposure ranged from ⁇ 79 to ⁇ 84%.
- the exposure of Eud-Alg hydrogel capsules to 40° C. for 10 min can reduce the weights of the hydrogel capsule by about 13%.
- Exposure of the Eud-Alg hydrogel capsules to 60° C. or 80° C. for 10 min can reduce the weights of the hydrogel capsules by about 27% and 33% of, respectively.
- Exposure of the Eud-Alg hydrogel capsules to 120° C. for 5 min can reduce the weight of the capsules by about 32.5%.
- the 24% ACAP-Eud-Alg hydrogel capsules exhibited the lowest weight loss after heat exposure at 60° C. for 10 min.
- the thermal effect may be attributed to increased mobility of the polymer chains at higher temperatures and to improved consolidation by the inter-diffusion of polymer chains as Eudragit® particles aggregate within the coating layer, driven by capillary action that promotes water evaporation during thermal exposure. Efficient coating/film formation and efficient coalescence of dispersed latexes can generally be achieved at temperatures above the T g of the latex polymer of Eudragit®. Based on DSC analysis, phase transitions of Eudragit® were observed at 58° C. and 125° C.
- the Eudragit® copolymer can assume a more flexible rubbery state that can contribute to a more suitable coating/film. Exposing Eud-coated alginate hydrogel capsules to 120° C. for 5 minutes can induce stress relaxation and promote the orientation of the Eudragit® copolymer to alter the coating layer morphology conducive in preventing water diffusion through the Eudragit® coating.
- FIG. 16A shows the surface morphology of ACAP-Eud-Alg hydrogel capsules not exposed to heat.
- FIG. 17A an array of circular indentations, or pits were observed on the surface. Larger indentations were usually arranged along a linear pathway, and were surrounded by smaller pits that were about 20 ⁇ m in pore size.
- FIG. 16B shows the surface morphology of ACAP-Eud-Alg hydrogel capsules exposed to 60° C. for 10 min.
- FIG. 17B some significant morphological changes were observed on the surface of hydrogel capsules subjected to heat exposure. A large number of randomly shaped depressions were observed on the surface after 60° C. treatment for 10 min. Large depressions were concentrated on the peaks, but as the valleys were approached, the depressions decreased in size, and were spread over a larger surface area. These depressions were not pores.
- Eudragit® has a reported glass transition temperature (T g ) of 115° C. Above T g , the mobility of the polymer chain increases, and may significantly impact the permeability of Eudragit® coating. The length of time for each heat exposure was optimized to minimize the water evaporation during the evaluation process.
- FIG. 17 shows water-retention profiles, expressed as % weight retention, for various combinations of coating formulations deposited on the surface of alginate hydrogel capsules, measured at room conditions 23° C. and RH 50%.
- the Eud-Alg hydrogel capsules not subjected to pH or heat treated could not effectively inhibit the evaporation of water from the alginate gel matrix when compared to uncoated alginate hydrogel capsules (negative control).
- the 24% ACAP-Eud-coated hydrogel capsules that were exposed to heat demonstrated improved water retention properties with aging, but only moderately.
- Table 2 below provides % weight retention measured for various combinations of coating formulations plotted in FIG. 18 .
- “Open” samples were stored in open trays at room condition 74° F. and 50% RH.
- “Close” samples were stored at room condition 74° F. and 50% RH in 32 ml vials with snap caps
- the wax coatings significantly improved the percent water retention.
- the type of wax selected can make a significant contribution to the effectiveness of the coating in preventing water loss.
- Polyester-wax-coated hydrogel capsules exhibited 95.6% water retention after one week of aging.
- carnauba-wax-coated hydrogel capsules exhibited 97.6% water retention after the same time period.
- Paraffin wax formed the most effective water-impermeable coating layer, as the Paraffin Wax-Eud-coated alginate hydrogel capsules demonstrated almost 100% water retention when left in an open tray at 23° C. and 50% RH for fifteen weeks (three months).
- Wax is highly hydrophobic and contains large content of long-chain alkanes.
- a coating layer comprising a wax formulation can be effective in forming a low-permeability coating layer that can be deposited onto the surface of hydrogel capsules containing a substantial amount of water.
- Any natural polymer can be employed for producing the hydrogel matrix, such as alginate, to serve as a carrier of water, water-soluble flavors, or water-soluble active agent of interest.
- the hydrogels enveloped by the disclosed coating formulations exhibit desirable properties, including mechanical strength and low-permeability. Unlike the film-coating processes described herein for the formation of latex-like/polymer coatings, the dip-wax coating process does not require the use of solvents that may lead to environmental problems, solvent residues, or excessive recovery costs.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Materials Engineering (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Formation And Processing Of Food Products (AREA)
Abstract
Description
TABLE 1 | |||||
Original | Water Loss | ||||
Water | after heat | % Water post- | |||
Content | Temp | exposure | heat exposure | ||
Beads | (%) | (° C.) | Time (min) | (wt. %) | (wt. %) |
Eud-Alg | 86 ± 1 | 40 | 10 | 13.6 ± 3 | 84 ± 3 |
Eud-Alg | 86 ± 1 | 60 | 10 | 27.6 ± 3 | 81 ± 3 |
Eud-Alg | 86 ± 1 | 80 | 10 | 32.9 ± 3 | 79 ± 3 |
Eud-Alg | 86 ± 1 | 120 | 5 | 32.5 ± 3 | 79 ± 3 |
24% | 78 ± 1 | 60 | 10 | 8.3 ± 3 | 76 ± 3 |
ACAP- | |||||
Eud- | |||||
Alg | |||||
TABLE 2 | ||
Water Retention (%) with Storage at 74° F. (23° C.) and 50 |
1 |
2 |
3 weeks | 4 weeks | 5 weeks |
Bead Type | Open | Close | Open | Close | Open | Close | Open | Close | Open | Close |
Alginate alone | 0 | 87 | 0 | 74.3 | 0 | 66.6 | 0 | 53.4 | 0 | 21.7 |
Eud-coated | 0 | 91.6 | 0 | 81.5 | 0 | 74.1 | 0 | 61.3 | 0 | 57.5 |
Polyesterwax-Eud | 95.6 | — | — | — | — | — | — | — | — | — |
Carnaubawax-Eud | 97.6 | — | 96.5 | — | 95.6 | — | 94.8 | — | 93.9 | — |
Paraffinwax- |
100 | — | 100 | — | 100 | — | 100 | — | 100 | — |
Water Retention (%) with Storage at 74° F. (23° C.) and 50% RH |
7 weeks | 9 weeks | 11 weeks | 13 |
15 weeks |
Bead Type | Open | Close | Open | Close | Open | Close | Open | Close | Open | Close |
Alginate alone | 0 | 0 | — | 0 | — | 0 | — | 0 | — | |
Eud-coated | 0 | 0 | — | 0 | — | 0 | — | 0 | — | |
Polyesterwax-Eud | — | — | — | — | — | — | — | — | — | — |
Carnaubawax-Eud | — | — | — | — | — | — | — | |||
Paraffinwax- |
100 | — | 100 | — | 100 | — | 100 | — | 100 | — |
Claims (9)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/612,881 US8663671B2 (en) | 2009-11-05 | 2009-11-05 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
PCT/EP2010/006722 WO2011054516A2 (en) | 2009-11-05 | 2010-11-04 | Methods and compositions for producing tobacco products containing hydrogel capsules coated for low permeability and physical integrity |
US14/163,657 US9167848B2 (en) | 2009-11-05 | 2014-01-24 | Method and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
US14/873,261 US9661875B2 (en) | 2009-11-05 | 2015-10-02 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
US15/493,745 US20170225143A1 (en) | 2009-11-05 | 2017-04-21 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/612,881 US8663671B2 (en) | 2009-11-05 | 2009-11-05 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/163,657 Division US9167848B2 (en) | 2009-11-05 | 2014-01-24 | Method and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
Publications (2)
Publication Number | Publication Date |
---|---|
US20110104218A1 US20110104218A1 (en) | 2011-05-05 |
US8663671B2 true US8663671B2 (en) | 2014-03-04 |
Family
ID=43856271
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/612,881 Active 2030-01-26 US8663671B2 (en) | 2009-11-05 | 2009-11-05 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
US14/163,657 Active US9167848B2 (en) | 2009-11-05 | 2014-01-24 | Method and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
US14/873,261 Active US9661875B2 (en) | 2009-11-05 | 2015-10-02 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
US15/493,745 Abandoned US20170225143A1 (en) | 2009-11-05 | 2017-04-21 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/163,657 Active US9167848B2 (en) | 2009-11-05 | 2014-01-24 | Method and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
US14/873,261 Active US9661875B2 (en) | 2009-11-05 | 2015-10-02 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
US15/493,745 Abandoned US20170225143A1 (en) | 2009-11-05 | 2017-04-21 | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
Country Status (2)
Country | Link |
---|---|
US (4) | US8663671B2 (en) |
WO (1) | WO2011054516A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109078580A (en) * | 2018-09-10 | 2018-12-25 | 张津 | A kind of environment-friendly biomass fuel pellet moulding device |
WO2020089065A1 (en) * | 2018-10-29 | 2020-05-07 | Nerudia Limited | Smoking substitute consumable |
US11064730B2 (en) | 2016-07-11 | 2021-07-20 | Philip Morris Products S.A. | Hydrophobic capsule |
EP4062775A1 (en) * | 2021-03-26 | 2022-09-28 | JT International SA | Tobacco product for hnb devices |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL199781A0 (en) | 2009-07-09 | 2010-05-17 | Yohai Zorea | Heat resistant probiotic compositions and healthy food comprising them |
US9743688B2 (en) | 2010-03-26 | 2017-08-29 | Philip Morris Usa Inc. | Emulsion/colloid mediated flavor encapsulation and delivery with tobacco-derived lipids |
CA2796346C (en) | 2010-04-14 | 2018-10-02 | Altria Client Services Inc. | Preformed smokeless tobacco product |
US20130156858A1 (en) * | 2010-06-03 | 2013-06-20 | Rph Pharmaceuticals Ab | Formulations Preserving Bioactivity and Methods of Their Preparation |
US20120000481A1 (en) * | 2010-06-30 | 2012-01-05 | Dennis Potter | Degradable filter element for smoking article |
KR101110271B1 (en) * | 2011-07-14 | 2012-02-15 | 팜드림주식회사 | Dairy products of containing functional alginic acid bead and manufacturing method thereof |
WO2013093912A1 (en) * | 2011-12-19 | 2013-06-27 | SPAI Group Ltd. | Compositions and methods for improving stability and extending shelf life of flavoring agents |
WO2013128253A1 (en) * | 2012-02-29 | 2013-09-06 | Itc Limited | Polymeric powdered coating composition for making liquid filled polymeric beads and methods thereof |
WO2013192413A1 (en) * | 2012-06-20 | 2013-12-27 | Mishra Munmaya K | Smokeless tobacco comprising lipid granules |
GB201220280D0 (en) * | 2012-11-12 | 2012-12-26 | British American Tobacco Co | Products including capsules, uses and preparation thereof |
TWI512103B (en) | 2012-11-12 | 2015-12-11 | Ind Tech Res Inst | Cell culture system and serum-free method for culturing cell |
CN102920022B (en) * | 2012-11-16 | 2014-06-04 | 江苏中烟工业有限责任公司 | Preparation method of additive for reducing content of ammonia in mainstream smoke of cigarette and application of preparation method |
BR112015010480B1 (en) | 2012-11-23 | 2019-07-16 | Unilever N.V. | PARTICULATE, PARTICULAR VEHICLE OF CORE BENEFIT AGENT AND COVERAGE, PRODUCT MANUFACTURING PROCESS, SUBSTRATE TREATMENT METHOD AND HOUSEHOLD OR PERSONAL COMPOSITION |
TW201427719A (en) * | 2012-12-18 | 2014-07-16 | Philip Morris Products Sa | Encapsulated volatile liquid source for an aerosol-generating system |
GB201222986D0 (en) | 2012-12-20 | 2013-01-30 | British American Tobacco Co | Smokeless oral tobacco product and preparation thereof |
CN103074801B (en) * | 2013-01-30 | 2014-08-27 | 湖北中烟工业有限责任公司 | Forming paper paint for reducing hazardous substances in cigarette smoke |
US10799548B2 (en) * | 2013-03-15 | 2020-10-13 | Altria Client Services Llc | Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products |
US20150226497A1 (en) * | 2014-02-11 | 2015-08-13 | The Regents Of The University Of California | Thermal Devices For Controlling Heat Transfer |
US9528983B2 (en) * | 2014-05-12 | 2016-12-27 | Anna Merritt Holmes | Physicochemical modification and application of alginate gels for the controlled release of reagents in classical solution assays and microfluidic assays |
US20160044955A1 (en) * | 2014-08-13 | 2016-02-18 | R.J. Reynolds Tobacco Company | Smokeless tobacco products |
WO2016069903A1 (en) * | 2014-10-29 | 2016-05-06 | Altria Client Services Llc | E-vaping cartridge |
UA123389C2 (en) | 2014-10-29 | 2021-03-31 | Олтріа Клайєнт Сервісиз Ллк | Ethanol-free gel formulation cartridge for e-vaping device |
CN104726199B (en) * | 2015-02-06 | 2017-02-22 | 上海华宝生物科技有限公司 | Water-bearing capsule and preparation method thereof |
CN105105334A (en) * | 2015-07-17 | 2015-12-02 | 云南中烟工业有限责任公司 | Spice slow-release filter tip additive with polymer covering film as well as preparation method and application thereof |
US10870129B1 (en) | 2016-03-04 | 2020-12-22 | Alexander Dragan | Vapor infusion method and device |
JP6987782B2 (en) | 2016-04-19 | 2022-01-05 | アルトリア クライアント サービシーズ エルエルシー | Application of flavoring particles to give flavor in the filter of smoking goods |
GB201608947D0 (en) * | 2016-05-20 | 2016-07-06 | British American Tobacco Co | Consumable for aerosol generating device |
GB201608943D0 (en) | 2016-05-20 | 2016-07-06 | British American Tobacco Co | Capsule for tobacco industry product |
US10334873B2 (en) | 2016-06-16 | 2019-07-02 | Altria Client Services Llc | Breakable capsules and methods of forming thereof |
CN106220875B (en) * | 2016-07-20 | 2018-11-02 | 湖北中烟工业有限责任公司 | A kind of moisture-proof crisp cigarette capsule base material and preparation method thereof of increasing |
CN106220905B (en) * | 2016-08-30 | 2018-05-25 | 湖北中烟工业有限责任公司 | A kind of raising cigarette dripping pill lapping of dripping pill stability and preparation method thereof |
CN106914196A (en) * | 2017-04-11 | 2017-07-04 | 江南大学 | It is a kind of that the method for carrying water microcapsules is prepared based on liquid hoodle |
EP3614869B1 (en) | 2017-04-24 | 2024-11-06 | Swedish Match North Europe AB | A flavoured moist oral pouched nicotine product comprising triglyceride |
US10499686B2 (en) | 2017-06-23 | 2019-12-10 | Altria Client Services Llc | Smoking article filter with flavorant delivery system |
CN108323800B (en) * | 2017-12-18 | 2020-11-13 | 云南中烟工业有限责任公司 | Preparation method of cigarette core rod for heating non-combustible cigarette |
CN108579634B (en) * | 2018-04-13 | 2020-11-20 | 天津工业大学 | Preparation method of hydrophobic amine capsule |
KR102583754B1 (en) * | 2018-05-21 | 2023-09-26 | 차이나 토바코 후난 인더스트리얼 코포레이션 리미티드 | Low-temperature smoking body and method of manufacturing the same |
GB201812497D0 (en) * | 2018-07-31 | 2018-09-12 | Nicoventures Holdings Ltd | Aerosol generation |
GB201812498D0 (en) * | 2018-07-31 | 2018-09-12 | Nicoventures Holdings Ltd | Aerosol generation |
BR112021001925A2 (en) * | 2018-07-31 | 2021-04-27 | Nicoventures Trading Limited | method for making an aerosol generating material, material, substrate, article and assembly |
GB201812496D0 (en) * | 2018-07-31 | 2018-09-12 | Nicoventures Holdings Ltd | Aerosol generation |
GB201812510D0 (en) * | 2018-07-31 | 2018-09-12 | Nicoventures Holdings Ltd | Aerosol generation |
CN109222226A (en) * | 2018-08-28 | 2019-01-18 | 中国烟草总公司郑州烟草研究院 | A kind of cigarette capsule and preparation method thereof wrapping up hydrogel beads |
CN108669641A (en) * | 2018-08-28 | 2018-10-19 | 中国烟草总公司郑州烟草研究院 | A kind of cigarette capsule and preparation method thereof of package water |
CN108851216A (en) * | 2018-08-28 | 2018-11-23 | 中国烟草总公司郑州烟草研究院 | A kind of wax packet emulsion type cigarette capsule and preparation method thereof |
CN109222223A (en) * | 2018-08-28 | 2019-01-18 | 中国烟草总公司郑州烟草研究院 | A kind of wax water-in type cigarette is with quick-fried pearl and preparation method thereof |
CN109043644B (en) * | 2018-08-28 | 2022-02-08 | 中国烟草总公司郑州烟草研究院 | Three-layer structure cigarette capsule simultaneously coated with lipid solution and water and preparation method thereof |
CN109567261A (en) * | 2018-11-27 | 2019-04-05 | 江苏万腾新材料科技有限公司 | Using water-soluble material as three layers of cigarette capsule of core material and preparation method thereof |
CN109846083A (en) * | 2019-02-22 | 2019-06-07 | 广西中烟工业有限责任公司 | A kind of cigarette of appearance setting waterproof wax coat is with quick-fried pearl and preparation method thereof |
CN109820243A (en) * | 2019-03-15 | 2019-05-31 | 湖北中烟工业有限责任公司 | Have effects that the scented gel of sustained release and its preparation and the application in cigarette |
CN110127742A (en) * | 2019-04-21 | 2019-08-16 | 宣城新威华化工科技有限公司 | A kind of method of producing nano-calcium carbonate for water paint |
US11213062B2 (en) | 2019-05-09 | 2022-01-04 | American Snuff Company | Stabilizer for moist snuff |
CN110419774A (en) * | 2019-07-10 | 2019-11-08 | 云南巴菰生物科技有限公司 | A kind of quick-fried pearl of water and preparation method thereof with double rubber layers |
KR102330307B1 (en) * | 2019-10-11 | 2021-11-24 | 주식회사 케이티앤지 | Aerosol generating article comprising triple capsule and aerosol generating system using the same |
CN111084415A (en) * | 2019-11-12 | 2020-05-01 | 云南中烟工业有限责任公司 | Wax-sealed water blasting bead and preparation method and device thereof |
CN111067136A (en) * | 2019-11-13 | 2020-04-28 | 湖北中烟工业有限责任公司 | Material for low-temperature cigarette cooling section and preparation method and application thereof |
GB201917472D0 (en) * | 2019-11-29 | 2020-01-15 | Nicoventures Trading Ltd | Aerosol generation |
GB201917492D0 (en) * | 2019-11-29 | 2020-01-15 | Nicoventures Trading Ltd | Aerosol generation |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
AU2020400391A1 (en) * | 2019-12-09 | 2022-06-30 | Nicoventures Trading Limited | Oral product with multiple flavors having different release profiles |
US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US20210169783A1 (en) * | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Oral products with controlled release |
CN111602845B (en) * | 2020-04-27 | 2022-08-09 | 深圳烟草工业有限责任公司 | Cigarette cooling gel particles and application thereof |
CN111729624B (en) * | 2020-07-08 | 2021-04-02 | 江苏科技大学 | Preparation and application method of biogel for environmental remediation |
KR20230068413A (en) * | 2020-09-11 | 2023-05-17 | 니코벤처스 트레이딩 리미티드 | Alginate-based substrate |
CN112263016A (en) * | 2020-11-17 | 2021-01-26 | 云南中烟工业有限责任公司 | Solid gel cigarette rod, preparation method thereof and cigarette comprising solid gel cigarette rod |
CN113331473B (en) * | 2021-06-10 | 2023-10-13 | 五邑大学 | Water-soluble essence-coated cigarette explosion bead and preparation method thereof |
FR3124929A1 (en) | 2021-07-09 | 2023-01-13 | V. Mane Fils | POLYVINYLIDENE FILM-COATED FLAVORED HEART-SHELL CAPSULES |
WO2023083962A1 (en) * | 2021-11-10 | 2023-05-19 | Jt International Sa | Surface treatment for tobacco material |
CN114540183B (en) * | 2022-02-23 | 2024-09-06 | 邱红华 | Automatic liquid changing device |
Citations (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4350679A (en) | 1980-05-08 | 1982-09-21 | Eisai Co., Ltd. | Soft capsule coated with a film of carnauba wax and process for the preparation of the same |
WO1985002972A1 (en) | 1984-01-13 | 1985-07-18 | Plant Genetics, Inc. | Coating hydrogel capsules |
US4715143A (en) | 1984-01-13 | 1987-12-29 | Plant Genetics, Inc. | Artificial seed coat for botanic seed analogs |
US4910021A (en) | 1985-11-29 | 1990-03-20 | R. P. Scherer Corporation | Targeted enternal delivery system |
US4967772A (en) | 1987-08-13 | 1990-11-06 | C.A. Blockers, Inc. | Tobacco smoking article and treatment of tobacco smoke with at least one alcohol |
US5016655A (en) | 1986-10-21 | 1991-05-21 | C.A. Blockers, Inc. | Cigarette manufacturing process |
US5096717A (en) | 1989-09-07 | 1992-03-17 | Ciba-Geigy Corporation | Double-coated granules of disodium pamidronate |
US5330759A (en) | 1992-08-26 | 1994-07-19 | Sterling Winthrop Inc. | Enteric coated soft capsules and method of preparation thereof |
WO1997002020A1 (en) | 1995-07-05 | 1997-01-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
US5843479A (en) | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
US6197331B1 (en) | 1997-07-24 | 2001-03-06 | Perio Products Ltd. | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity |
US6312728B1 (en) | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
US6365189B1 (en) | 1999-10-22 | 2002-04-02 | 3M Innovative Properties Company | Method of delivering and releasing a pheromone |
JP2003201256A (en) | 2001-12-28 | 2003-07-18 | Hisamitsu Pharmaceut Co Inc | Colic delivery oral pharmaceutical preparation, oral pharmaceutical preparation for treatment of colon cancer and oral pharmaceutical preparation for treating colitis |
WO2003059503A1 (en) | 2002-01-08 | 2003-07-24 | Analytical Research Systems | Hydrocapsules and method of preparation |
WO2004041251A1 (en) | 2002-11-04 | 2004-05-21 | Ocean Nutrition Canada Limited | Microcapsules having multiple shells and method for the preparation thereof |
US6780507B2 (en) * | 2000-02-09 | 2004-08-24 | Analytical Research Systems, Inc. | Hydrocapsules and method of preparation thereof |
US6858666B2 (en) | 2002-03-04 | 2005-02-22 | Aveka, Inc. | Organogel particles |
US20050142199A1 (en) | 2002-02-28 | 2005-06-30 | Wei Tian | Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38 n/sqcm and a coating to protect the soft core |
US6923988B2 (en) | 1999-11-23 | 2005-08-02 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20050271724A1 (en) | 2004-06-07 | 2005-12-08 | Wyeth | Sugar coatings and methods therefor |
EP1607087A1 (en) | 2003-03-27 | 2005-12-21 | Hisamitsu Pharmaceutical Co., Inc. | Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis |
US20060115529A1 (en) | 2003-05-07 | 2006-06-01 | Seonghoon Jeong | Fast-melting tablets having taste-masking and sustained release properties |
US20060144412A1 (en) | 2004-12-30 | 2006-07-06 | Philip Morris Usa Inc. | Encapsulated additives and methods of making encapsulated additives |
US20060191548A1 (en) * | 2003-11-07 | 2006-08-31 | Strickland James A | Tobacco compositions |
WO2006109194A2 (en) | 2005-01-27 | 2006-10-19 | Ocean Nutrition Canada Ltd. | Chromium-fatty acid compounds and methods of making and using thereof |
WO2007002516A2 (en) | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Improved dosage forms for movement disorder treatment |
US20070003619A1 (en) | 2002-12-20 | 2007-01-04 | St. James Associates Llc/Faber Research Series | Coated particles for sustained-release pharmaceutical administration |
US20070145617A1 (en) | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Processes for producing microencapsulated heat delivery vehicles |
US20070145618A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Methods of making microencapsulated delivery vehicles |
US20080286408A1 (en) | 2006-12-28 | 2008-11-20 | Philip Morris Usa Inc. | Encapsulation of a hydrophilic substance in small capsules |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6585666B2 (en) * | 1998-10-13 | 2003-07-01 | The Administrators Of The Tulane Educational Fund | Arthroscopic diagnostic probe to measure mechanical properties of articular cartilage |
US8157918B2 (en) * | 2005-09-30 | 2012-04-17 | Philip Morris Usa Inc. | Menthol cigarette |
CA2702737A1 (en) * | 2007-10-16 | 2009-04-23 | Hkpb Scientific Limited | Surface coating processes and uses of same |
-
2009
- 2009-11-05 US US12/612,881 patent/US8663671B2/en active Active
-
2010
- 2010-11-04 WO PCT/EP2010/006722 patent/WO2011054516A2/en active Application Filing
-
2014
- 2014-01-24 US US14/163,657 patent/US9167848B2/en active Active
-
2015
- 2015-10-02 US US14/873,261 patent/US9661875B2/en active Active
-
2017
- 2017-04-21 US US15/493,745 patent/US20170225143A1/en not_active Abandoned
Patent Citations (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4350679A (en) | 1980-05-08 | 1982-09-21 | Eisai Co., Ltd. | Soft capsule coated with a film of carnauba wax and process for the preparation of the same |
WO1985002972A1 (en) | 1984-01-13 | 1985-07-18 | Plant Genetics, Inc. | Coating hydrogel capsules |
US4715143A (en) | 1984-01-13 | 1987-12-29 | Plant Genetics, Inc. | Artificial seed coat for botanic seed analogs |
US4910021A (en) | 1985-11-29 | 1990-03-20 | R. P. Scherer Corporation | Targeted enternal delivery system |
US5016655A (en) | 1986-10-21 | 1991-05-21 | C.A. Blockers, Inc. | Cigarette manufacturing process |
US4967772A (en) | 1987-08-13 | 1990-11-06 | C.A. Blockers, Inc. | Tobacco smoking article and treatment of tobacco smoke with at least one alcohol |
US5096717A (en) | 1989-09-07 | 1992-03-17 | Ciba-Geigy Corporation | Double-coated granules of disodium pamidronate |
US5330759A (en) | 1992-08-26 | 1994-07-19 | Sterling Winthrop Inc. | Enteric coated soft capsules and method of preparation thereof |
US5843479A (en) | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
WO1997002020A1 (en) | 1995-07-05 | 1997-01-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
US6197331B1 (en) | 1997-07-24 | 2001-03-06 | Perio Products Ltd. | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity |
US6312728B1 (en) | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
US6365189B1 (en) | 1999-10-22 | 2002-04-02 | 3M Innovative Properties Company | Method of delivering and releasing a pheromone |
US6923988B2 (en) | 1999-11-23 | 2005-08-02 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6780507B2 (en) * | 2000-02-09 | 2004-08-24 | Analytical Research Systems, Inc. | Hydrocapsules and method of preparation thereof |
JP2003201256A (en) | 2001-12-28 | 2003-07-18 | Hisamitsu Pharmaceut Co Inc | Colic delivery oral pharmaceutical preparation, oral pharmaceutical preparation for treatment of colon cancer and oral pharmaceutical preparation for treating colitis |
WO2003059503A1 (en) | 2002-01-08 | 2003-07-24 | Analytical Research Systems | Hydrocapsules and method of preparation |
US20050142199A1 (en) | 2002-02-28 | 2005-06-30 | Wei Tian | Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38 n/sqcm and a coating to protect the soft core |
US6858666B2 (en) | 2002-03-04 | 2005-02-22 | Aveka, Inc. | Organogel particles |
WO2004041251A1 (en) | 2002-11-04 | 2004-05-21 | Ocean Nutrition Canada Limited | Microcapsules having multiple shells and method for the preparation thereof |
US20070003619A1 (en) | 2002-12-20 | 2007-01-04 | St. James Associates Llc/Faber Research Series | Coated particles for sustained-release pharmaceutical administration |
EP1607087A1 (en) | 2003-03-27 | 2005-12-21 | Hisamitsu Pharmaceutical Co., Inc. | Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis |
US20060115529A1 (en) | 2003-05-07 | 2006-06-01 | Seonghoon Jeong | Fast-melting tablets having taste-masking and sustained release properties |
US20060191548A1 (en) * | 2003-11-07 | 2006-08-31 | Strickland James A | Tobacco compositions |
US20050271724A1 (en) | 2004-06-07 | 2005-12-08 | Wyeth | Sugar coatings and methods therefor |
US20060144412A1 (en) | 2004-12-30 | 2006-07-06 | Philip Morris Usa Inc. | Encapsulated additives and methods of making encapsulated additives |
WO2006109194A2 (en) | 2005-01-27 | 2006-10-19 | Ocean Nutrition Canada Ltd. | Chromium-fatty acid compounds and methods of making and using thereof |
WO2007002516A2 (en) | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Improved dosage forms for movement disorder treatment |
US20070003621A1 (en) | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US20070145617A1 (en) | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Processes for producing microencapsulated heat delivery vehicles |
US20070145618A1 (en) * | 2005-12-28 | 2007-06-28 | Kimberly-Clark Worldwide, Inc. | Methods of making microencapsulated delivery vehicles |
US20080286408A1 (en) | 2006-12-28 | 2008-11-20 | Philip Morris Usa Inc. | Encapsulation of a hydrophilic substance in small capsules |
Non-Patent Citations (2)
Title |
---|
International Preliminary Report on Patentability issued May 8, 2012 for PCT/EP2011/006722. |
International Search Report (Form PCT/ISA/210) and Written Opinion of the International Searching Authority (Form PCT/ISA/237) dated Jun. 20, 2011, issued by the European Patent Office in corresponding International Patent Application No. PCT/EP2010/006722. |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11064730B2 (en) | 2016-07-11 | 2021-07-20 | Philip Morris Products S.A. | Hydrophobic capsule |
US11849756B2 (en) | 2016-07-11 | 2023-12-26 | Philip Morris Products S.A. | Hydrophobic capsule |
CN109078580A (en) * | 2018-09-10 | 2018-12-25 | 张津 | A kind of environment-friendly biomass fuel pellet moulding device |
WO2020089065A1 (en) * | 2018-10-29 | 2020-05-07 | Nerudia Limited | Smoking substitute consumable |
EP4442129A3 (en) * | 2018-10-29 | 2024-11-06 | Imperial Tobacco Limited | Smoking substitute consumable |
EP4062775A1 (en) * | 2021-03-26 | 2022-09-28 | JT International SA | Tobacco product for hnb devices |
Also Published As
Publication number | Publication date |
---|---|
WO2011054516A3 (en) | 2011-08-11 |
US20160095347A1 (en) | 2016-04-07 |
US20140137878A1 (en) | 2014-05-22 |
US9167848B2 (en) | 2015-10-27 |
US20170225143A1 (en) | 2017-08-10 |
US20110104218A1 (en) | 2011-05-05 |
WO2011054516A2 (en) | 2011-05-12 |
US9661875B2 (en) | 2017-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9661875B2 (en) | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity | |
JP6154865B2 (en) | Smokeless tobacco products containing effervescent compositions | |
JP6154399B2 (en) | Smokeless tobacco products containing effervescent compositions | |
JP6182161B2 (en) | Multi-layer smokeless tobacco composition | |
EP2645885B1 (en) | Smokeless tobacco pastille and moulding process for forming smokeless tobacco products | |
CN104363778B (en) | Smokeless tobacco product containing starch ingredients | |
US20130263870A1 (en) | Smokeless tobacco pastille and moulding process for forming smokeless tobacco products | |
US20210169123A1 (en) | Pouched products with enhanced flavor stability | |
WO2021086367A1 (en) | Oral product and method of manufacture | |
US11826462B2 (en) | Oral product with sustained flavor release | |
US11883527B2 (en) | Oral composition and method of manufacture | |
US20210169785A1 (en) | Oral compositions with reduced water activity | |
US20210169783A1 (en) | Oral products with controlled release | |
US20210170031A1 (en) | Oral composition with nanocrystalline cellulose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PHILIP MORRIS USA INC., VIRGINIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KARLES, GEORGIOS D.;ZHUANG, SHUZHONG;REEL/FRAME:024655/0101 Effective date: 20100114 |
|
AS | Assignment |
Owner name: PHILIP MORRIS USA INC., VIRGINIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WU, DAQING;REEL/FRAME:024871/0389 Effective date: 20100712 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551) Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |